tiprankstipranks
Advertisement
Advertisement
Biogen Rated Buy as RayThera Acquisition Bolsters Immunology Pipeline and Long-Term Growth Prospects
PremiumRatingsBiogen Rated Buy as RayThera Acquisition Bolsters Immunology Pipeline and Long-Term Growth Prospects
14d ago
Biogen price target raised to $224 from $206 at Morgan Stanley
Premium
The Fly
Biogen price target raised to $224 from $206 at Morgan Stanley
14d ago
M&A News: Biogen to Acquire RayThera for Up to $1B, Expanding Drug Pipeline
Premium
Market News
M&A News: Biogen to Acquire RayThera for Up to $1B, Expanding Drug Pipeline
14d ago
Biogen Shareholders Back Board, Auditor and Pay Policies
PremiumCompany AnnouncementsBiogen Shareholders Back Board, Auditor and Pay Policies
22d ago
Needham upgrades Biogen on pipeline potential, stabilizing core business
Premium
The Fly
Needham upgrades Biogen on pipeline potential, stabilizing core business
24d ago
Biogen upgraded to Buy from Hold at Needham
Premium
The Fly
Biogen upgraded to Buy from Hold at Needham
24d ago
Biogen and Denali’s BIIB122 Parkinson’s Trial Completion Sets Up Key Catalyst for Investors
PremiumCompany AnnouncementsBiogen and Denali’s BIIB122 Parkinson’s Trial Completion Sets Up Key Catalyst for Investors
1M ago
Biogen price target raised to $227 from $222 at RBC Capital
Premium
The Fly
Biogen price target raised to $227 from $222 at RBC Capital
1M ago
Biogen and Denali’s Parkinson’s candidate did not meet Phase 2b endpoints
Premium
The Fly
Biogen and Denali’s Parkinson’s candidate did not meet Phase 2b endpoints
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100